Pfizer Inc. (PFE) PE Ratio: 19.58
Is Pfizer Inc.’s P/E ratio high or low?
Pfizer Inc.'s P/E ratio of 19.58 is in line with its 5-year average of 18.18, near the low end of its 5-year range (6.90–79.96).
The P/E ratio for Pfizer Inc. (PFE) is 19.58 as of Wednesday, June 10, 2026. It is above its 12-month average by 19.68% (16.36).
PE Ratio (19.58) = Close Price ($25.66) / Diluted TTM EPS ($1.31)
PFE PE Ratio Chart
PFE Average PE Ratio Chart
PFE Current vs Average PE Ratio Chart
PFE PE Ratio Metrics
PE RATIO
19.58
PE RATIO AVG TTM
16.36
PE RATIO AVG 3Y
22.40
PE RATIO AVG 5Y
18.18
PE RATIO AVG 10Y
18.64
PE RATIO AVG 15Y
17.98
PE RATIO AVG 20Y
16.88
CURRENT VS TTM AVG
+19.68%
CURRENT VS 3Y AVG
-12.58%
CURRENT VS 5Y AVG
+7.70%
CURRENT VS 10Y AVG
+5.03%
CURRENT VS 15Y AVG
+8.88%
CURRENT VS 20Y AVG
+15.97%
PFE Competitors' PE Ratio
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pfizer Inc. (PFE) | $146.36B | 19.58 | 16.36 | 22.40 | 18.18 |
| Intuitive Surgical, Inc. (ISRG) | $146.44B | 50.15 | 65.94 | 75.04 | 71.85 |
| Gilead Sciences, Inc. (GILD) | $151.21B | 16.58 | 21.34 | 157.50 | 110.62 |
| Abbott Laboratories (ABT) | $154.66B | 24.74 | 19.30 | 27.88 | 28.20 |
| Danaher Corporation (DHR) | $130.25B | 35.67 | 41.62 | 38.62 | 34.94 |
| CVS Health Corporation (CVS) | $125.16B | 43.22 | 81.81 | 37.72 | 30.77 |
| Bristol-Myers Squibb Company (BMY) | $114.14B | 15.70 | 17.63 | 16.34 | 19.37 |
| Thermo Fisher Scientific Inc. (TMO) | $179.45B | 26.55 | 29.20 | 32.54 | 31.18 |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.77B | 25.92 | 29.54 | 29.28 | 27.23 |
| Amgen Inc. (AMGN) | $183.75B | 23.67 | 25.06 | 29.63 | 26.36 |
P/E vs. its own history
At 19.6, P/E is richer than usual — richer than 72% of its 20-year range.
20-year low
6.9
median
15.1
20-year high
80.0
P/E Comparison
Trailing P/E
19.6
Forward P/E
9.1
Forward P/E Calculation
View All Analyst EstimatesForward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$25.66
Forward EPS (Est.)
$2.83
Forward P/E
9.06
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
Pfizer Inc. PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Pfizer Inc. PE Ratio FAQ
- What is the P/E ratio for Pfizer Inc. (PFE)?
- The P/E ratio for PFE stock is 19.58.
- Is Pfizer Inc.'s P/E ratio high or low?
- Pfizer Inc.'s P/E ratio of 19.58 is in line with its 5-year average of 18.18, near the low end of its 5-year range (6.90–79.96).
- What is the TTM average P/E ratio for Pfizer Inc. (PFE)?
- The TTM average P/E ratio for PFE stock is 16.36.
- What is the 3Y average P/E ratio for Pfizer Inc. (PFE)?
- The 3Y average P/E ratio for PFE stock is 22.40.
- What is the 5Y average P/E ratio for Pfizer Inc. (PFE)?
- The 5Y average P/E ratio for PFE stock is 18.18.
- What is the 10Y average P/E ratio for Pfizer Inc. (PFE)?
- The 10Y average P/E ratio for PFE stock is 18.64.
- What is the 15Y average P/E ratio for Pfizer Inc. (PFE)?
- The 15Y average P/E ratio for PFE stock is 17.98.
- What is the 20Y average P/E ratio for Pfizer Inc. (PFE)?
- The 20Y average P/E ratio for PFE stock is 16.88.
Pfizer Inc. PE Ratio History
| DATE | PE RATIO |
|---|---|
| 2026-06-10 | 19.58 |
| 2026-06-09 | 19.62 |
| 2026-06-08 | 19.56 |
| 2026-06-05 | 19.88 |
| 2026-06-04 | 19.61 |
| 2026-06-03 | 19.34 |
| 2026-06-02 | 19.50 |
| 2026-06-01 | 19.56 |
| 2026-05-29 | 19.98 |
| 2026-05-28 | 19.95 |
| 2026-05-27 | 20.01 |
| 2026-05-26 | 19.73 |
| 2026-05-22 | 19.77 |
| 2026-05-21 | 19.81 |
| 2026-05-20 | 19.69 |
| 2026-05-19 | 19.59 |
| 2026-05-18 | 19.34 |
| 2026-05-15 | 19.34 |
| 2026-05-14 | 19.66 |
| 2026-05-13 | 19.82 |
| 2026-05-12 | 19.75 |
| 2026-05-11 | 19.70 |
| 2026-05-08 | 19.60 |
| 2026-05-07 | 20.21 |
| 2026-05-06 | 20.25 |
| 2026-05-05 | 20.19 |
| 2026-05-04 | 19.34 |
| 2026-05-01 | 19.37 |
| 2026-04-30 | 19.64 |
| 2026-04-29 | 19.31 |
| 2026-04-28 | 19.48 |
| 2026-04-27 | 19.70 |
| 2026-04-24 | 19.86 |
| 2026-04-23 | 19.62 |
| 2026-04-22 | 19.71 |
| 2026-04-21 | 20.09 |
| 2026-04-20 | 20.24 |
| 2026-04-17 | 20.27 |
| 2026-04-16 | 20.02 |
| 2026-04-15 | 20.00 |
| 2026-04-14 | 19.94 |
| 2026-04-13 | 20.11 |
| 2026-04-10 | 19.80 |
| 2026-04-09 | 20.02 |
| 2026-04-08 | 20.20 |
| 2026-04-07 | 19.93 |
| 2026-04-06 | 20.47 |
| 2026-04-02 | 20.83 |
| 2026-04-01 | 21.00 |
| 2026-03-31 | 20.65 |
| 2026-03-30 | 20.43 |
| 2026-03-27 | 19.89 |
| 2026-03-26 | 20.28 |
| 2026-03-25 | 20.06 |
| 2026-03-24 | 19.83 |
| 2026-03-23 | 19.69 |
| 2026-03-20 | 19.84 |
| 2026-03-19 | 20.16 |
| 2026-03-18 | 20.09 |
| 2026-03-17 | 20.19 |
| 2026-03-16 | 19.57 |
| 2026-03-13 | 19.55 |
| 2026-03-12 | 19.76 |
| 2026-03-11 | 20.08 |
| 2026-03-10 | 19.98 |
| 2026-03-09 | 19.72 |
| 2026-03-06 | 19.90 |
| 2026-03-05 | 19.57 |
| 2026-03-04 | 19.58 |
| 2026-03-03 | 19.55 |
| 2026-03-02 | 20.05 |
| 2026-02-27 | 20.34 |
| 2026-02-26 | 19.93 |
| 2026-02-25 | 15.74 |
| 2026-02-24 | 15.77 |
| 2026-02-23 | 15.72 |
| 2026-02-20 | 15.48 |
| 2026-02-19 | 15.60 |
| 2026-02-18 | 15.90 |
| 2026-02-17 | 15.90 |
| 2026-02-13 | 16.02 |
| 2026-02-12 | 15.96 |
| 2026-02-11 | 16.11 |
| 2026-02-10 | 16.04 |
| 2026-02-09 | 15.71 |
| 2026-02-06 | 15.81 |
| 2026-02-05 | 15.39 |
| 2026-02-04 | 15.56 |
| 2026-02-03 | 14.97 |
| 2026-02-02 | 15.49 |
| 2026-01-30 | 15.36 |
| 2026-01-29 | 15.16 |
| 2026-01-28 | 15.02 |
| 2026-01-27 | 15.39 |
| 2026-01-26 | 15.03 |
| 2026-01-23 | 14.90 |
| 2026-01-22 | 15.16 |
| 2026-01-21 | 15.04 |
| 2026-01-20 | 14.82 |
| 2026-01-16 | 14.90 |
| 2026-01-15 | 15.04 |
| 2026-01-14 | 14.86 |
| 2026-01-13 | 14.61 |
| 2026-01-12 | 14.68 |
| 2026-01-09 | 14.80 |
| 2026-01-08 | 14.69 |
| 2026-01-07 | 14.68 |
| 2026-01-06 | 14.77 |
| 2026-01-05 | 14.62 |
| 2026-01-02 | 14.63 |
| 2025-12-31 | 14.46 |
| 2025-12-30 | 14.52 |
| 2025-12-29 | 14.52 |
| 2025-12-26 | 14.57 |
| 2025-12-24 | 14.54 |
| 2025-12-23 | 14.45 |
| 2025-12-22 | 14.64 |
| 2025-12-19 | 14.63 |
| 2025-12-18 | 14.55 |
| 2025-12-17 | 14.55 |
| 2025-12-16 | 14.83 |
| 2025-12-15 | 15.35 |
| 2025-12-12 | 15.02 |
| 2025-12-11 | 14.99 |
| 2025-12-10 | 14.98 |
| 2025-12-09 | 14.71 |
| 2025-12-08 | 14.97 |
| 2025-12-05 | 15.12 |
| 2025-12-04 | 14.93 |
| 2025-12-03 | 14.85 |
| 2025-12-02 | 14.61 |
| 2025-12-01 | 14.68 |
| 2025-11-28 | 14.95 |
| 2025-11-26 | 14.93 |
| 2025-11-25 | 14.94 |
| 2025-11-24 | 14.65 |
| 2025-11-21 | 14.55 |
| 2025-11-20 | 14.17 |
| 2025-11-19 | 14.45 |
| 2025-11-18 | 14.78 |
| 2025-11-17 | 14.57 |
| 2025-11-14 | 14.56 |
| 2025-11-13 | 14.98 |
| 2025-11-12 | 15.03 |
| 2025-11-11 | 14.82 |
| 2025-11-10 | 14.17 |
| 2025-11-07 | 14.19 |
| 2025-11-06 | 14.44 |
| 2025-11-05 | 14.30 |
| 2025-11-04 | 14.12 |
| 2025-11-03 | 13.08 |
| 2025-10-31 | 13.07 |
| 2025-10-30 | 12.88 |
| 2025-10-29 | 12.88 |
| 2025-10-28 | 12.99 |
| 2025-10-27 | 13.14 |
| 2025-10-24 | 13.13 |
| 2025-10-23 | 13.08 |
| 2025-10-22 | 13.11 |
| 2025-10-21 | 13.18 |
| 2025-10-20 | 13.09 |
| 2025-10-17 | 13.00 |
| 2025-10-16 | 12.85 |
| 2025-10-15 | 12.94 |
| 2025-10-14 | 13.00 |
| 2025-10-13 | 13.12 |
| 2025-10-10 | 13.14 |
| 2025-10-09 | 13.39 |
| 2025-10-08 | 13.62 |
| 2025-10-07 | 13.93 |
| 2025-10-06 | 14.02 |
| 2025-10-03 | 14.52 |
| 2025-10-02 | 14.36 |
| 2025-10-01 | 14.43 |
| 2025-09-30 | 13.51 |
| 2025-09-29 | 12.65 |
| 2025-09-26 | 12.60 |
| 2025-09-25 | 12.52 |
| 2025-09-24 | 12.78 |
| 2025-09-23 | 12.80 |
| 2025-09-22 | 12.75 |
| 2025-09-19 | 12.74 |
| 2025-09-18 | 12.81 |
| 2025-09-17 | 12.76 |
| 2025-09-16 | 12.68 |
| 2025-09-15 | 12.71 |
| 2025-09-12 | 12.66 |
| 2025-09-11 | 13.18 |
| 2025-09-10 | 13.03 |
| 2025-09-09 | 13.11 |
| 2025-09-08 | 13.02 |
| 2025-09-05 | 13.20 |
| 2025-09-04 | 13.02 |
| 2025-09-03 | 13.15 |
| 2025-09-02 | 13.25 |
| 2025-08-29 | 13.13 |
| 2025-08-28 | 13.05 |
| 2025-08-27 | 13.30 |
| 2025-08-26 | 13.22 |
| 2025-08-25 | 13.33 |
| 2025-08-22 | 13.73 |
| 2025-08-21 | 13.65 |
| 2025-08-20 | 13.46 |
| 2025-08-19 | 13.43 |
| 2025-08-18 | 13.30 |
| 2025-08-15 | 13.33 |
| 2025-08-14 | 13.32 |
| 2025-08-13 | 13.34 |
| 2025-08-12 | 13.07 |
| 2025-08-11 | 13.04 |
| 2025-08-08 | 13.04 |
| 2025-08-07 | 12.85 |
| 2025-08-06 | 12.69 |
| 2025-08-05 | 13.13 |
| 2025-08-04 | 17.05 |
| 2025-08-01 | 17.03 |
| 2025-07-31 | 16.88 |
| 2025-07-30 | 17.26 |
| 2025-07-29 | 17.61 |
| 2025-07-28 | 17.62 |
| 2025-07-25 | 17.97 |
| 2025-07-24 | 18.37 |
| 2025-07-23 | 18.38 |
| 2025-07-22 | 18.22 |
| 2025-07-21 | 17.58 |
| 2025-07-18 | 17.74 |
| 2025-07-17 | 17.82 |
| 2025-07-16 | 17.84 |
| 2025-07-15 | 17.84 |
| 2025-07-14 | 18.37 |
| 2025-07-11 | 18.59 |
| 2025-07-10 | 18.69 |
| 2025-07-09 | 18.53 |
| 2025-07-08 | 18.57 |
| 2025-07-07 | 18.29 |
| 2025-07-03 | 18.40 |
| 2025-07-02 | 18.35 |
| 2025-07-01 | 18.15 |
| 2025-06-30 | 17.57 |
| 2025-06-27 | 17.53 |
| 2025-06-26 | 17.57 |
| 2025-06-25 | 17.58 |
| 2025-06-24 | 17.62 |
| 2025-06-23 | 17.42 |
| 2025-06-20 | 17.37 |
| 2025-06-18 | 17.31 |
| 2025-06-17 | 17.40 |
| 2025-06-16 | 17.69 |
| 2025-06-13 | 17.79 |
| 2025-06-12 | 18.00 |
| 2025-06-11 | 17.74 |
| 2025-06-10 | 17.61 |
| 2025-06-09 | 17.37 |
| 2025-06-06 | 16.92 |
| 2025-06-05 | 16.76 |
| 2025-06-04 | 16.95 |
| 2025-06-03 | 16.92 |
| 2025-06-02 | 17.00 |
| 2025-05-30 | 17.03 |
| 2025-05-29 | 17.00 |
Showing the most recent 260 of 4,907 data points. The chart above shows the full history.
Related Metrics
About Pfizer Inc.
Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Albert Bourla